Sex: F
Vaccine: COVID19, COVID19, FLUX, VARZOS
Symptoms: Blister, Burning sensation, Rash erythematous, Rash macular, Rash papular
Clinical narrative: macular rash, on legs; papular rash, on legs; pruritic rash, on legs; erythematous rash, on legs; 5 blisters; dot lesions; felt like someone burned; This case was reported by a consumer via call center representative and described the occurrence of macular rash in a 50-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu unspecified (Influenza vaccine) for prophylaxis, COVID-19 VACCINE for prophylaxis and COVID-19 VACCINE (COVID-19 BOOSTER) for prophylaxis.   The patient's past medical history included colonoscopy (preventative care such as having a colonoscopy when she turned age 50). Previously administered products included hepatitis B vaccine (received vaccine on an unknown date, as a child and had no risk factors for hepatitis B.).   On an unknown date, the patient received the 1st dose of Shingrix, Influenza vaccine, COVID-19 VACCINE and COVID-19 BOOSTER. On an unknown date, 1 month after receiving Shingrix and less than 3 months after receiving Influenza vaccine, the patient experienced macular rash, papular rash, itchy rash, red rash, blister, skin lesion and burning sensation. On an unknown date, the outcome of the macular rash, papular rash, itchy rash, red rash and burning sensation were unknown and the outcome of the blister and skin lesion were not recovered/not resolved.   It was unknown if the reporter considered the macular rash, papular rash, itchy rash, red rash, blister, skin lesion and burning sensation to be related to Shingrix and Influenza vaccine.     Additional Information: GSK receipt date: 21-OCT-2022 Reporter's comment: The reporter was the patient. She indicated that she was healthy and had a good diet and exercises.  She did preventative care such as having a colonoscopy when she turned age 50.  Also she tries to follow state guidelines when it comes to vaccines.  The patient had in short order, the flu shot, covid both booster and then the first dose of shingrix. A month after the shingrix shot, she was seeing macular papular pruritic erythematous rash, primarily on her legs. It was annoying and bothersome, but she was not had any of the other severe reactions listed on website and materials. She was going to wait 6 months and take the second dose, but see that it was contraindicated if hypersensitive to the first dose.  The patient was trying to map out a good plan of action. She did not have money to go to a medical provider. She had to get off the phone thus she was not able to obtain her date of birth, MD contact information, ask if she had the lot number of the Shingrix, or probe to seek the brand name of the flu shot. She said it currently was about 5 blisters that were dot lesions.  She said she would rate her rash as 2.5 to 3.5 on a rash scale. She said it was not severe.  She said that in the past the rash felt like someone burned me with a lighter, Patient indicated that she wanted to get the Shingrix shot 2, if possible, to complete the series. She feels like that she was just having a response because she got three shots (flu, Covid, and Shingrix) in a 5 week period.  Less than 3 months after Covid 19 vaccines, the patient experienced was macular rash, papular rash, itchy rash, red rash and unknown after shingrix vaccine, flu vaccine and covid 19 vaccine the patient experienced blister, skin lesion and burning sensation.  The reporter stated that her state was now recommending adults get their Hepatitis B shot she was considering whether or not she will get the hepatitis B shot since she already had the hepatitis B vaccine as a child and has no risk factors for hepatitis B. It was unknown if the reporter considered the macular rash, papular rash, itchy rash, red rash, blister, skin lesion and burning sensation to be related to Covid 19 vaccine.